{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:01:13Z","timestamp":1794664873332,"version":"4.9.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University","award":["2024-LCYJ-PY-59"],"award-info":[{"award-number":["2024-LCYJ-PY-59"]}]},{"name":"Medical New Technology Development Project of Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School","award":["XJSFZLX202321"],"award-info":[{"award-number":["XJSFZLX202321"]}]},{"name":"Project of The National Health Commission Health Development Research Center","award":["No. WKZX2023CX020001"],"award-info":[{"award-number":["No. WKZX2023CX020001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13874-x","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T10:24:17Z","timestamp":1745317457000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of an RNA-binding protein group on regulating the RSPO-LGR4\/5-ZNRF3\/RNF43 module and the immune microenvironment in hepatocellular carcinoma"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5380-8316","authenticated-orcid":false,"given":"Zhengyao","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"13874_CR1","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clinicians. 2021;71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","DOI":"10.3322\/caac.21660"},{"key":"13874_CR2","doi-asserted-by":"publisher","unstructured":"Chrysavgis L, Giannakodimos I, Diamantopoulou P, Cholongitas E. Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link. World Journal of Gastroenterology. 2022;28(3):310\u2013331. https:\/\/doi.org\/10.3748\/wjg.v28.i3.310","DOI":"10.3748\/wjg.v28.i3.310"},{"key":"13874_CR3","doi-asserted-by":"publisher","unstructured":"Toh MR, Wong EYT, Wong SH, et al. Global Epidemiology and Genetics of Hepatocellular Carcinoma. Gastroenterology. 2023;164(5):766\u2013782. https:\/\/doi.org\/10.1053\/j.gastro.2023.01.033","DOI":"10.1053\/j.gastro.2023.01.033"},{"key":"13874_CR4","doi-asserted-by":"publisher","unstructured":"Zhai X, Zhang H, Xia Z, et al. Oxytocin alleviates liver fibrosis via hepatic macrophages. JHEP Rep. 2024;6(6):101032. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101032","DOI":"10.1016\/j.jhepr.2024.101032"},{"key":"13874_CR5","doi-asserted-by":"publisher","unstructured":"Zhang H, Xia T, Xia Z, et al. KIF18A inactivates hepatic stellate cells and alleviates liver fibrosis through the TTC3\/Akt\/mTOR pathway. Cell Mol Life Sci. 2024;81(1):96. https:\/\/doi.org\/10.1007\/s00018-024-05114-5","DOI":"10.1007\/s00018-024-05114-5"},{"key":"13874_CR6","doi-asserted-by":"publisher","unstructured":"Zhang X, Zhang P, Cong A, et al. Unraveling molecular networks in thymic epithelial tumors: deciphering the unique signatures. Front Immunol. 2023;14:1264325. https:\/\/doi.org\/10.3389\/fimmu.2023.1264325","DOI":"10.3389\/fimmu.2023.1264325"},{"key":"13874_CR7","doi-asserted-by":"publisher","unstructured":"Shibata T. Genomic landscape of hepatocarcinogenesis. J Hum Genet. 2021;66(9):845\u2013851. https:\/\/doi.org\/10.1038\/s10038-021-00928-8","DOI":"10.1038\/s10038-021-00928-8"},{"key":"13874_CR8","doi-asserted-by":"publisher","unstructured":"Zhang K, Barry AE, Lamm R, Patel K, Schafer M, Dang H. The role of RNA binding proteins in hepatocellular carcinoma. Advanced Drug Delivery Reviews. 2022;182. https:\/\/doi.org\/10.1016\/j.addr.2022.114114","DOI":"10.1016\/j.addr.2022.114114"},{"key":"13874_CR9","doi-asserted-by":"publisher","unstructured":"Wang S, Sun Z, Lei Z, Zhang HT. RNA-binding proteins and cancer metastasis. Semin Cancer Biol. 2022;86(Pt 2):748\u2013768. https:\/\/doi.org\/10.1016\/j.semcancer.2022.03.018","DOI":"10.1016\/j.semcancer.2022.03.018"},{"key":"13874_CR10","doi-asserted-by":"publisher","unstructured":"Kechavarzi B, Janga S. Dissecting the expression landscape of RNA-binding proteins in human cancers. Genome Biol. 2014;15(1):R14. https:\/\/doi.org\/10.1186\/gb-2014-15-1-r14","DOI":"10.1186\/gb-2014-15-1-r14"},{"key":"13874_CR11","doi-asserted-by":"publisher","unstructured":"Xiao R, Chen JY, Liang Z, et al. Pervasive Chromatin-RNA Binding Protein Interactions Enable RNA-Based Regulation of Transcription. Cell. 2019;178(1):107\u2013121.e18. https:\/\/doi.org\/10.1016\/j.cell.2019.06.001","DOI":"10.1016\/j.cell.2019.06.001"},{"key":"13874_CR12","doi-asserted-by":"publisher","unstructured":"David CJ, Manley JL. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev. 2010;24(21):2343\u20132364. https:\/\/doi.org\/10.1101\/gad.1973010","DOI":"10.1101\/gad.1973010"},{"key":"13874_CR13","doi-asserted-by":"publisher","unstructured":"Gautrey H, Jackson C, Dittrich AL, Browell D, Lennard T, Tyson-Capper A. SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells. RNA Biol. 2015;12(10):1139\u20131151. https:\/\/doi.org\/10.1080\/15476286.2015.1076610","DOI":"10.1080\/15476286.2015.1076610"},{"key":"13874_CR14","doi-asserted-by":"publisher","unstructured":"Masamha CP, Xia Z, Yang J, et al. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression. Nature. 2014;510(7505):412\u2013416. https:\/\/doi.org\/10.1038\/nature13261","DOI":"10.1038\/nature13261"},{"key":"13874_CR15","doi-asserted-by":"publisher","unstructured":"Guo X, Hartley RS. HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells. Cancer Res. 2006;66(16):7948\u20137956. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-4362","DOI":"10.1158\/0008-5472.CAN-05-4362"},{"key":"13874_CR16","doi-asserted-by":"publisher","unstructured":"H\u00fcttelmaier S, Zenklusen D, Lederer M, et al. Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1. Nature. 2005;438(7067):512\u2013515. https:\/\/doi.org\/10.1038\/nature04115","DOI":"10.1038\/nature04115"},{"key":"13874_CR17","doi-asserted-by":"publisher","unstructured":"Ripin N, Parker R. Formation, function, and pathology of RNP granules. Cell. 2023;186(22):4737\u20134756. https:\/\/doi.org\/10.1016\/j.cell.2023.09.006","DOI":"10.1016\/j.cell.2023.09.006"},{"key":"13874_CR18","doi-asserted-by":"publisher","unstructured":"Qin H, Ni H, Liu Y, et al. RNA-binding proteins in tumor progression. J Hematol Oncol. 2020;13(1):90. https:\/\/doi.org\/10.1186\/s13045-020-00927-w","DOI":"10.1186\/s13045-020-00927-w"},{"key":"13874_CR19","doi-asserted-by":"publisher","unstructured":"Dang H, Takai A, Forgues M, et al. Oncogenic Activation of the RNA Binding Protein NELFE and MYC Signaling in Hepatocellular Carcinoma. Cancer Cell. 2017;32(1):101\u2013114.e8. https:\/\/doi.org\/10.1016\/j.ccell.2017.06.002","DOI":"10.1016\/j.ccell.2017.06.002"},{"key":"13874_CR20","doi-asserted-by":"publisher","unstructured":"Dang H, Pomyen Y, Martin SP, et al. NELFE-Dependent MYC Signature Identifies a Unique Cancer Subtype in Hepatocellular Carcinoma. Sci Rep. 2019;9(1):3369. https:\/\/doi.org\/10.1038\/s41598-019-39727-9","DOI":"10.1038\/s41598-019-39727-9"},{"key":"13874_CR21","doi-asserted-by":"publisher","unstructured":"Luo C, Cheng Y, Liu Y, et al. SRSF2 Regulates Alternative Splicing to Drive Hepatocellular Carcinoma Development. Cancer Res. 2017;77(5):1168\u20131178. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1919","DOI":"10.1158\/0008-5472.CAN-16-1919"},{"key":"13874_CR22","doi-asserted-by":"publisher","unstructured":"Ale-Agha N, Galban S, Sobieroy C, et al. HuR regulates gap junctional intercellular communication by controlling beta-catenin levels and adherens junction integrity. Hepatology. 2009;50(5):1567\u20131576. https:\/\/doi.org\/10.1002\/hep.23146","DOI":"10.1002\/hep.23146"},{"key":"13874_CR23","doi-asserted-by":"publisher","unstructured":"V\u00e1zquez-Chantada M, Fern\u00e1ndez-Ramos D, Embade N, et al. HuR\/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis. Gastroenterology. 2010;138(5):1943\u20131953. https:\/\/doi.org\/10.1053\/j.gastro.2010.01.032","DOI":"10.1053\/j.gastro.2010.01.032"},{"key":"13874_CR24","doi-asserted-by":"publisher","unstructured":"Mohibi S, Chen X, Zhang J. Cancer the\u2018RBP\u2019eutics\u2013RNA-binding proteins as therapeutic targets for cancer. Pharmacology & Therapeutics. 2019;203:107390. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.07.001","DOI":"10.1016\/j.pharmthera.2019.07.001"},{"key":"13874_CR25","doi-asserted-by":"publisher","unstructured":"Lang M, Berry D, Passecker K, et al. HuR Small-Molecule Inhibitor Elicits Differential Effects in Adenomatosis Polyposis and Colorectal Carcinogenesis. Cancer Res. 2017;77(9):2424\u20132438. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1726","DOI":"10.1158\/0008-5472.CAN-15-1726"},{"key":"13874_CR26","doi-asserted-by":"publisher","unstructured":"Wu X, Lan L, Wilson DM, et al. Identification and validation of novel small molecule disruptors of HuR-mRNA interaction. ACS Chem Biol. 2015;10(6):1476\u20131484. https:\/\/doi.org\/10.1021\/cb500851u","DOI":"10.1021\/cb500851u"},{"key":"13874_CR27","doi-asserted-by":"publisher","unstructured":"Licatalosi DD, Mele A, Fak JJ, et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature. 2008;456(7221):464\u2013469. https:\/\/doi.org\/10.1038\/nature07488","DOI":"10.1038\/nature07488"},{"key":"13874_CR28","doi-asserted-by":"publisher","unstructured":"Van Nostrand EL, Pratt GA, Shishkin AA, et al. Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP). Nat Methods. 2016;13(6):508\u2013514. https:\/\/doi.org\/10.1038\/nmeth.3810","DOI":"10.1038\/nmeth.3810"},{"key":"13874_CR29","doi-asserted-by":"publisher","unstructured":"Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6","DOI":"10.1038\/s41467-019-09234-6"},{"key":"13874_CR30","doi-asserted-by":"publisher","unstructured":"Chen C, Wu Y, Li J, et al. TBtools-II: A \u201cone for all, all for one\u201d bioinformatics platform for biological big-data mining. Mol Plant. 2023;16(11):1733\u20131742. https:\/\/doi.org\/10.1016\/j.molp.2023.09.010","DOI":"10.1016\/j.molp.2023.09.010"},{"key":"13874_CR31","doi-asserted-by":"publisher","unstructured":"Tang D, Chen M, Huang X, et al. SRplot: A free online platform for data visualization and graphing. PLoS One. 2023;18(11):e0294236. https:\/\/doi.org\/10.1371\/journal.pone.0294236","DOI":"10.1371\/journal.pone.0294236"},{"key":"13874_CR32","doi-asserted-by":"publisher","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Winckler W, et al. Integrative Genomics Viewer. Nat Biotechnol. 2011;29(1):24\u201326. https:\/\/doi.org\/10.1038\/nbt.1754","DOI":"10.1038\/nbt.1754"},{"key":"13874_CR33","doi-asserted-by":"publisher","unstructured":"Gao FB, Carson CC, Levine T, Keene JD. Selection of a subset of mRNAs from combinatorial 3\u2019 untranslated region libraries using neuronal RNA-binding protein Hel-N1. Proc Natl Acad Sci U S A. 1994;91(23):11207\u201311211. https:\/\/doi.org\/10.1073\/pnas.91.23.11207","DOI":"10.1073\/pnas.91.23.11207"},{"key":"13874_CR34","doi-asserted-by":"publisher","unstructured":"Keene JD. The globalization of messenger RNA regulation. Natl Sci Rev. 2014;1(2):184\u2013186. https:\/\/doi.org\/10.1093\/nsr\/nwu004","DOI":"10.1093\/nsr\/nwu004"},{"key":"13874_CR35","doi-asserted-by":"publisher","unstructured":"Blackinton JG, Keene JD. Post-transcriptional RNA regulons affecting cell cycle and proliferation. Seminars in Cell & Developmental Biology. 2014;34:44\u201354. https:\/\/doi.org\/10.1016\/j.semcdb.2014.05.014","DOI":"10.1016\/j.semcdb.2014.05.014"},{"key":"13874_CR36","doi-asserted-by":"publisher","unstructured":"Bisogno LS, Keene JD. Analysis of post-transcriptional regulation during cancer progression using a donor-derived isogenic model of tumorigenesis. Methods. 2017;126:193\u2013200. https:\/\/doi.org\/10.1016\/j.ymeth.2017.05.012","DOI":"10.1016\/j.ymeth.2017.05.012"},{"key":"13874_CR37","doi-asserted-by":"publisher","unstructured":"Kechavarzi B, Janga SC. Dissecting the expression landscape of RNA-binding proteins in human cancers. Genome Biol. 2014;15(1):R14. https:\/\/doi.org\/10.1186\/gb-2014-15-1-r14","DOI":"10.1186\/gb-2014-15-1-r14"},{"key":"13874_CR38","doi-asserted-by":"publisher","unstructured":"Bisogno LS, Keene JD. RNA regulons in cancer and inflammation. Curr Opin Genet Dev. 2018;48:97\u2013103. https:\/\/doi.org\/10.1016\/j.gde.2017.11.004","DOI":"10.1016\/j.gde.2017.11.004"},{"key":"13874_CR39","doi-asserted-by":"publisher","unstructured":"Yang H, Beutler B, Zhang D. Emerging roles of spliceosome in cancer and immunity. Protein Cell. 2022;13(8):559\u2013579. https:\/\/doi.org\/10.1007\/s13238-021-00856-5","DOI":"10.1007\/s13238-021-00856-5"},{"key":"13874_CR40","doi-asserted-by":"publisher","unstructured":"Marcelo A, Koppenol R, de Almeida LP, Matos CA, N\u00f3brega C. Stress granules, RNA-binding proteins and polyglutamine diseases: too much aggregation? Cell Death Dis. 2021;12(6):592. https:\/\/doi.org\/10.1038\/s41419-021-03873-8","DOI":"10.1038\/s41419-021-03873-8"},{"key":"13874_CR41","doi-asserted-by":"publisher","unstructured":"Ivanov P, Kedersha N, Anderson P. Stress Granules and Processing Bodies in Translational Control. Cold Spring Harb Perspect Biol. 2019;11(5):a032813. https:\/\/doi.org\/10.1101\/cshperspect.a032813","DOI":"10.1101\/cshperspect.a032813"},{"key":"13874_CR42","doi-asserted-by":"publisher","unstructured":"Van Nostrand EL, Freese P, Pratt GA, et al. A large-scale binding and functional map of human RNA-binding proteins. Nature. 2020;583(7818):711\u2013719. https:\/\/doi.org\/10.1038\/s41586-020-2077-3","DOI":"10.1038\/s41586-020-2077-3"},{"key":"13874_CR43","doi-asserted-by":"publisher","unstructured":"Ule J, Blencowe BJ. Alternative Splicing Regulatory Networks: Functions, Mechanisms, and Evolution. Molecular Cell. 2019;76(2):329\u2013345. https:\/\/doi.org\/10.1016\/j.molcel.2019.09.017","DOI":"10.1016\/j.molcel.2019.09.017"},{"key":"13874_CR44","doi-asserted-by":"publisher","unstructured":"Hawkins S, Mondaini A, Namboori SC, et al. ePRINT: exonuclease assisted mapping of protein-RNA interactions. Genome Biology. 2024;25(1):140. https:\/\/doi.org\/10.1186\/s13059-024-03271-1","DOI":"10.1186\/s13059-024-03271-1"},{"key":"13874_CR45","doi-asserted-by":"publisher","unstructured":"Policastro RA, Zentner GE. Global approaches for profiling transcription initiation. Cell Reports Methods. 2021;1(5):100081. https:\/\/doi.org\/10.1016\/j.crmeth.2021.100081","DOI":"10.1016\/j.crmeth.2021.100081"},{"key":"13874_CR46","doi-asserted-by":"publisher","unstructured":"Wang H, Wang R, Fang J. A spliceosome-associated gene signature aids in predicting prognosis and tumor microenvironment of hepatocellular carcinoma. Aging (Albany NY). 2023;15(11):4906\u20134925. https:\/\/doi.org\/10.18632\/aging.204765","DOI":"10.18632\/aging.204765"},{"key":"13874_CR47","doi-asserted-by":"publisher","unstructured":"Qiu J, Wu X, Luo Y, et al. Prognostic and immunotherapeutic predictive value of interleukin enhancer-binding factor 3 in hepatocellular carcinoma: Integrated bioinformatics and experimental analysis. Gene. 2023;856:147132. https:\/\/doi.org\/10.1016\/j.gene.2022.147132","DOI":"10.1016\/j.gene.2022.147132"},{"key":"13874_CR48","doi-asserted-by":"publisher","unstructured":"Jiang W, Huang H, Ding L, et al. Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability. Oncogene. 2015;34(34):4460\u20134470. https:\/\/doi.org\/10.1038\/onc.2014.373","DOI":"10.1038\/onc.2014.373"},{"key":"13874_CR49","doi-asserted-by":"publisher","unstructured":"Kang H, Heo S, Shin JJ, et al. A miR-194\/PTBP1\/CCND3 axis regulates tumor growth in human hepatocellular carcinoma. The Journal of Pathology. 2019;249(3):395\u2013408. https:\/\/doi.org\/10.1002\/path.5325","DOI":"10.1002\/path.5325"},{"key":"13874_CR50","doi-asserted-by":"publisher","unstructured":"Cho CY, Chung SY, Lin S, et al. PTBP1-mediated regulation of AXL mRNA stability plays a role in lung tumorigenesis. Sci Rep. 2019;9(1):16922. https:\/\/doi.org\/10.1038\/s41598-019-53097-2","DOI":"10.1038\/s41598-019-53097-2"},{"key":"13874_CR51","doi-asserted-by":"publisher","unstructured":"Mo Z, Qu H, Su R, et al. Effect of U2AF2 expression on proliferation and migration of hepatocellular carcinoma and its relationship with prognosis (in Chinese). Chinese Journal of Hepatic Surgery (Electronic Edition). 2023;12(3):336\u2013341. https:\/\/doi.org\/10.3877\/cma.j.issn.2095-3232.2023.03.017","DOI":"10.3877\/cma.j.issn.2095-3232.2023.03.017"},{"key":"13874_CR52","doi-asserted-by":"publisher","unstructured":"Glasser E, Maji D, Biancon G, et al. Pre-mRNA splicing factor U2AF2 recognizes distinct conformations of nucleotide variants at the center of the pre-mRNA splice site signal. Nucleic Acids Res. 2022;50(9):5299\u20135312. https:\/\/doi.org\/10.1093\/nar\/gkac287","DOI":"10.1093\/nar\/gkac287"},{"key":"13874_CR53","doi-asserted-by":"publisher","unstructured":"53. Zhou K, Yang J, Li X, Xiong W, Zhang P, Zhang X. N7-Methylguanosine Regulatory Genes Profoundly Affect the Prognosis, Progression, and Antitumor Immune Response of Hepatocellular Carcinoma. Front Surg. 2022;9:893977. https:\/\/doi.org\/10.3389\/fsurg.2022.893977","DOI":"10.3389\/fsurg.2022.893977"},{"key":"13874_CR54","doi-asserted-by":"publisher","unstructured":"Lodde V, Floris M, Munk R, et al. Systematic identification of NF90 target RNAs by iCLIP analysis. Scientific Reports. 2022;12(1). https:\/\/doi.org\/10.1038\/s41598-021-04101-1","DOI":"10.1038\/s41598-021-04101-1"},{"key":"13874_CR55","doi-asserted-by":"publisher","unstructured":"Shen L, Lei S, Zhang B, et al. Skipping of exon 10 in Axl pre-mRNA regulated by PTBP1 mediates invasion and metastasis process of liver cancer cells. Theranostics. 2020;10(13):5719\u20135735. https:\/\/doi.org\/10.7150\/thno.42010","DOI":"10.7150\/thno.42010"},{"key":"13874_CR56","doi-asserted-by":"publisher","unstructured":"He Z, Ni Q, Li X, Zhao M, Mo Q, Duo Y. PTBP1 promotes hepatocellular carcinoma progression by regulating the skipping of exon 9 in NUMB pre-mRNA. Heliyon. 2023;9(6):e17387. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17387","DOI":"10.1016\/j.heliyon.2023.e17387"},{"key":"13874_CR57","doi-asserted-by":"publisher","unstructured":"Zhao L, Zang Q, Liang G, Yao X. LncRNA CECR7 boosts hepatocellular carcinoma progression by recruiting RNA binding protein U2AF2 to enhance the stability of EXO1 mRNA. Heliyon. 2023;9(9):e19862. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19862","DOI":"10.1016\/j.heliyon.2023.e19862"},{"key":"13874_CR58","doi-asserted-by":"publisher","unstructured":"Perugorria MJ, Olaizola P, Labiano I, et al. Wnt-\u03b2-catenin signalling in liver development, health and disease. Nat Rev Gastroenterol Hepatol. 2019;16(2):121\u2013136. https:\/\/doi.org\/10.1038\/s41575-018-0075-9","DOI":"10.1038\/s41575-018-0075-9"},{"key":"13874_CR59","doi-asserted-by":"publisher","unstructured":"Khalaf AM, Fuentes D, Morshid AI, et al. Role of Wnt\/\u03b2-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance. J Hepatocell Carcinoma. 2018;5:61\u201373. https:\/\/doi.org\/10.2147\/JHC.S156701","DOI":"10.2147\/JHC.S156701"},{"key":"13874_CR60","doi-asserted-by":"publisher","unstructured":"Vilchez V, Turcios L, Marti F, Gedaly R. Targeting Wnt\/\u03b2-catenin pathway in hepatocellular carcinoma treatment. World J Gastroenterol. 2016;22(2):823\u2013832. https:\/\/doi.org\/10.3748\/wjg.v22.i2.823","DOI":"10.3748\/wjg.v22.i2.823"},{"key":"13874_CR61","doi-asserted-by":"publisher","unstructured":"Lee JM, Yang J, Newell P, et al. \u03b2-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation. Cancer Lett. 2014;343(1):90\u201397. https:\/\/doi.org\/10.1016\/j.canlet.2013.09.020","DOI":"10.1016\/j.canlet.2013.09.020"},{"key":"13874_CR62","doi-asserted-by":"publisher","unstructured":"Xu C, Xu Z, Zhang Y, Evert M, Calvisi DF, Chen X. \u03b2-Catenin signaling in hepatocellular carcinoma. J Clin Invest. 2022;132(4):e154515. https:\/\/doi.org\/10.1172\/JCI154515","DOI":"10.1172\/JCI154515"},{"key":"13874_CR63","doi-asserted-by":"publisher","unstructured":"Belenguer G, Mastrogiovanni G, Pacini C, et al. RNF43\/ZNRF3 loss predisposes to hepatocellular-carcinoma by impairing liver regeneration and altering the liver lipid metabolic ground-state. Nat Commun. 2022;13(1):334. https:\/\/doi.org\/10.1038\/s41467-021-27923-z","DOI":"10.1038\/s41467-021-27923-z"},{"key":"13874_CR64","doi-asserted-by":"publisher","unstructured":"Planas-Paz L, Orsini V, Boulter L, et al. The RSPO-LGR4\/5-ZNRF3\/RNF43 module controls liver zonation and size. Nat Cell Biol. 2016;18(5):467\u2013479. https:\/\/doi.org\/10.1038\/ncb3337","DOI":"10.1038\/ncb3337"},{"key":"13874_CR65","doi-asserted-by":"publisher","unstructured":"Sun T, Annunziato S, Bergling S, et al. ZNRF3 and RNF43 cooperate to safeguard metabolic liver zonation and hepatocyte proliferation. Cell Stem Cell. 2021;28(10):1822\u20131837 e10. https:\/\/doi.org\/10.1016\/j.stem.2021.05.013","DOI":"10.1016\/j.stem.2021.05.013"},{"key":"13874_CR66","doi-asserted-by":"publisher","unstructured":"Hao HX, Jiang X, Cong F. Control of Wnt Receptor Turnover by R-spondin-ZNRF3\/RNF43 Signaling Module and Its Dysregulation in Cancer. Cancers. 2016;8(6):54. https:\/\/doi.org\/10.3390\/cancers8060054","DOI":"10.3390\/cancers8060054"},{"key":"13874_CR67","doi-asserted-by":"publisher","unstructured":"Annunziato S, Sun T, Tchorz JS. The RSPO-LGR4\/5-ZNRF3\/RNF43 module in liver homeostasis, regeneration, and disease. Hepatology. 2022;76(3):888\u2013899. https:\/\/doi.org\/10.1002\/hep.32328","DOI":"10.1002\/hep.32328"},{"key":"13874_CR68","unstructured":"Xie H, Xing C, Cao G, et al. Association of RNF43 with cell cycle proteins involved in p53 pathway. Int J Clin Exp Pathol. 2015;8(11):14995\u201315000."},{"key":"13874_CR69","doi-asserted-by":"publisher","unstructured":"Zhuo H, Miao S, Jin Z, et al. Metformin Suppresses Hepatocellular Carcinoma through Regulating Alternative Splicing of LGR4. J Oncol. 2022;2022:1774095. https:\/\/doi.org\/10.1155\/2022\/1774095","DOI":"10.1155\/2022\/1774095"},{"key":"13874_CR70","doi-asserted-by":"publisher","unstructured":"Liu M, Zhao H, Peng S, et al. Comprehensive analysis of zinc and ring finger 3 in prognostic value and pan-cancer immunity. The FASEB Journal. 2024;38(5):e23523. https:\/\/doi.org\/10.1096\/fj.202301161R","DOI":"10.1096\/fj.202301161R"},{"key":"13874_CR71","doi-asserted-by":"publisher","unstructured":"Bi Y, Zhang L, Song Y, et al. Rspo2-LGR4 exacerbates hepatocellular carcinoma progression via activation of Wnt\/\u03b2-catenin signaling pathway. Gastroenterol Hepatol. 2024;47(4):352\u2013365. https:\/\/doi.org\/10.1016\/j.gastrohep.2023.05.016","DOI":"10.1016\/j.gastrohep.2023.05.016"},{"key":"13874_CR72","doi-asserted-by":"publisher","unstructured":"Schulze K, Imbeaud S, Letouz\u00e9 E, et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet. 2015;47(5):505\u2013511. https:\/\/doi.org\/10.1038\/ng.3252","DOI":"10.1038\/ng.3252"},{"key":"13874_CR73","doi-asserted-by":"publisher","unstructured":"Ong CK, Subimerb C, Pairojkul C, et al. Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat Genet. 2012;44(6):690\u2013693. https:\/\/doi.org\/10.1038\/ng.2273","DOI":"10.1038\/ng.2273"},{"key":"13874_CR74","doi-asserted-by":"publisher","unstructured":"Guichard C, Amaddeo G, Imbeaud S, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet. 2012;44(6):694\u2013698. https:\/\/doi.org\/10.1038\/ng.2256","DOI":"10.1038\/ng.2256"},{"key":"13874_CR75","doi-asserted-by":"publisher","unstructured":"Liu LJ, Xie SX, Chen YT, Xue JL, Zhang CJ, Zhu F. Aberrant regulation of Wnt signaling in hepatocellular carcinoma. World J Gastroenterol. 2016;22(33):7486\u20137499. https:\/\/doi.org\/10.3748\/wjg.v22.i33.7486","DOI":"10.3748\/wjg.v22.i33.7486"},{"key":"13874_CR76","doi-asserted-by":"publisher","unstructured":"Collu GM, Hidalgo-Sastre A, Brennan K. Wnt\u2013Notch signalling crosstalk in development and disease. Cell Mol Life Sci. 2014;71(18):3553\u20133567. https:\/\/doi.org\/10.1007\/s00018-014-1644-x","DOI":"10.1007\/s00018-014-1644-x"},{"key":"13874_CR77","doi-asserted-by":"publisher","unstructured":"Shorning BY, Dass MS, Smalley MJ, Pearson HB. The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling. Int J Mol Sci. 2020;21(12):4507. https:\/\/doi.org\/10.3390\/ijms21124507","DOI":"10.3390\/ijms21124507"},{"key":"13874_CR78","doi-asserted-by":"publisher","unstructured":"Zeng Q, Saghafinia S, Chryplewicz A, et al. Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion. Science. 2022;378(6621):eabl7207. https:\/\/doi.org\/10.1126\/science.abl7207","DOI":"10.1126\/science.abl7207"},{"key":"13874_CR79","doi-asserted-by":"publisher","unstructured":"Marasca F, Sinha S, Vadal\u00e0 R, et al. LINE1 are spliced in non-canonical transcript variants to regulate T cell quiescence and exhaustion. Nat Genet. 2022;54(2):180\u2013193. https:\/\/doi.org\/10.1038\/s41588-021-00989-7","DOI":"10.1038\/s41588-021-00989-7"},{"key":"13874_CR80","doi-asserted-by":"publisher","unstructured":"Elcheva IA, Gowda CP, Bogush D, et al. IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment. Front Immunol. 2023;14:1224516. https:\/\/doi.org\/10.3389\/fimmu.2023.1224516","DOI":"10.3389\/fimmu.2023.1224516"},{"key":"13874_CR81","doi-asserted-by":"publisher","unstructured":"Xie H, Xi X, Lei T, Liu H, Xia Z. CD8\u2009+\u2009T cell exhaustion in the tumor microenvironment of breast cancer. Front Immunol. 2024;15:1507283. https:\/\/doi.org\/10.3389\/fimmu.2024.1507283","DOI":"10.3389\/fimmu.2024.1507283"},{"key":"13874_CR82","doi-asserted-by":"publisher","unstructured":"Xia Z, Chen S, He M, et al. Editorial: Targeting metabolism to activate T cells and enhance the efficacy of checkpoint blockade immunotherapy in solid tumors. Front Immunol. 2023;14:1247178. https:\/\/doi.org\/10.3389\/fimmu.2023.1247178","DOI":"10.3389\/fimmu.2023.1247178"},{"key":"13874_CR83","doi-asserted-by":"publisher","unstructured":"Deng Y, Shi M, Yi L, Naveed Khan M, Xia Z, Li X. Eliminating a barrier: Aiming at VISTA, reversing MDSC-mediated T cell suppression in the tumor microenvironment. Heliyon. 2024;10(17):e37060. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37060","DOI":"10.1016\/j.heliyon.2024.e37060"},{"key":"13874_CR84","doi-asserted-by":"publisher","unstructured":"Hu Y, Hu Q, Li Y, et al. \u03b3\u03b4 T cells: origin and fate, subsets, diseases and immunotherapy. Sig Transduct Target Ther. 2023;8(1):1\u201338. https:\/\/doi.org\/10.1038\/s41392-023-01653-8","DOI":"10.1038\/s41392-023-01653-8"},{"key":"13874_CR85","doi-asserted-by":"publisher","unstructured":"He W, Hu Y, Chen D, et al. Hepatocellular carcinoma-infiltrating \u03b3\u03b4 T cells are functionally defected and allogenic V\u03b42\u2009+\u2009\u03b3\u03b4 T cell can be a promising complement. Clin Transl Med. 2022;12(4):e800. https:\/\/doi.org\/10.1002\/ctm2.800","DOI":"10.1002\/ctm2.800"},{"key":"13874_CR86","doi-asserted-by":"publisher","unstructured":"Craig AJ, von Felden J, Garcia-Lezana T, Sarcognato S, Villanueva A. Tumour evolution in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2020;17(3):139\u2013152. https:\/\/doi.org\/10.1038\/s41575-019-0229-4","DOI":"10.1038\/s41575-019-0229-4"},{"key":"13874_CR87","doi-asserted-by":"publisher","unstructured":"Nault JC, Villanueva A. Intratumor molecular and phenotypic diversity in hepatocellular carcinoma. Clin Cancer Res. 2015;21(8):1786\u20131788. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2602","DOI":"10.1158\/1078-0432.CCR-14-2602"},{"key":"13874_CR88","doi-asserted-by":"publisher","unstructured":"Zhou G, Sprengers D, Boor PPC, et al. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas. Gastroenterology. 2017;153(4):1107\u20131119.e10. https:\/\/doi.org\/10.1053\/j.gastro.2017.06.017","DOI":"10.1053\/j.gastro.2017.06.017"},{"key":"13874_CR89","doi-asserted-by":"publisher","unstructured":"Chen J, Lin Z, Liu L, et al. GOLM1 exacerbates CD8\u2009+\u2009T cell suppression in hepatocellular carcinoma by promoting exosomal PD-L1 transport into tumor-associated macrophages. Signal Transduct Target Ther. 2021;6(1):397. https:\/\/doi.org\/10.1038\/s41392-021-00784-0","DOI":"10.1038\/s41392-021-00784-0"},{"key":"13874_CR90","doi-asserted-by":"publisher","unstructured":"Nazitto R, Amon LM, Mast FD, et al. ILF3 Is a Negative Transcriptional Regulator of Innate Immune Responses and Myeloid Dendritic Cell Maturation. J Immunol. 2021;206(12):2949\u20132965. https:\/\/doi.org\/10.4049\/jimmunol.2001235","DOI":"10.4049\/jimmunol.2001235"},{"key":"13874_CR91","doi-asserted-by":"publisher","unstructured":"Jiang J, Mei J, Yi S, et al. Tumor associated macrophage and microbe: The potential targets of tumor vaccine delivery. Adv Drug Deliv Rev. 2022;180:114046. https:\/\/doi.org\/10.1016\/j.addr.2021.114046","DOI":"10.1016\/j.addr.2021.114046"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13874-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13874-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13874-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T10:24:20Z","timestamp":1745317460000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13874-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13874"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13874-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, with ethical approval number (2023-646-02).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study was conducted according to the guidelines laid down in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics declaration"}},{"value":"The patient\u2019s written informed consent was obtained for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"751"}}